Taking Ozempic? A routine eye exam could help you understand your risk for vision loss.
Published . Updated .
Some research suggests that GLP-1 drugs may raise the risk of a rare eye disease that causes full or partial vision loss.
Directly affected
- No company is named in this report.
Indirectly affected
- SFTY HORIZON FDS MANAGED RISK ETF
GA selected SFTY as a RELATED security because its canonical security name directly matches this event's themes: risk. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- XRMI GLOBAL X S&P 500 RISK MANAGED INCOME ETF
GA selected XRMI as a RELATED security because its canonical security name directly matches this event's themes: risk. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
Some research suggests that GLP-1 drugs may raise the risk of a rare eye disease that causes full or partial vision loss.
Source: MarketWatch
How far Horizon Fds Managed Risk Etf (SFTY) has moved since 28 Sep 2026
Since the first closing price after “Taking Ozempic? A routine eye exam could help you understand your risk for vision loss.,” Horizon Fds Managed Risk Etf (SFTY) is +1.04%. The S&P 500 fund (SPY) is +0.29% over the same days, a +0.75% difference versus the market.
Who gains and who loses around Horizon Fds Managed Risk Etf (SFTY)
Companies tied to this story
- SFTY Horizon Fds Managed Risk Etf
Horizon Fds Managed Risk Etf (SFTY) is linked, with no stored direction, medium confidence in the 28 Sep 2026 story “Taking Ozempic? A routine eye exam could help you understand your risk for vision loss..” Reason on file: GA selected SFTY as a RELATED security because its canonical security name directly matches this event's themes: risk. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- XRMI Global X S&P 500 Risk Managed Income Etf
In “Taking Ozempic? A routine eye exam could help you understand your risk for vision loss.,” Global X S&P 500 Risk Managed Income Etf (XRMI) is linked, with no stored direction, medium confidence. Reason on file: GA selected XRMI as a RELATED security because its canonical security name directly matches this event's themes: risk. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Horizon Fds Managed Risk Etf (SFTY)
The 28 Sep 2026 story “Taking Ozempic? A routine eye exam could help you understand your risk for vision loss.” names Horizon Fds Managed Risk Etf (SFTY) because of this story.
Horizon Fds Managed Risk Etf (SFTY) is on the page because GA selected SFTY as a RELATED security because its canonical security name directly matches this event's themes: risk. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Global X S&P 500 Risk Managed Income Etf (XRMI) is here too. Its reason reads: GA selected XRMI as a RELATED security because its canonical security name directly matches this event's themes: risk. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Dates in the story, and the Horizon Fds Managed Risk Etf (SFTY) price range
SFTY traded between 31.53 and 32.29 across 20 sessions. The latest close on file is 32.00. XRMI traded between 17.07 and 17.41 across 20 sessions. The latest close on file is 17.08.
What the saved facts support for Horizon Fds Managed Risk Etf (SFTY)
21 out of 100
“Taking Ozempic? A routine eye exam could help you understand your risk for vision loss.” scores 21 out of 100. The score uses 1 sources, and 2 linked companies.